Form 4: Quoin Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Dennis Langer, a Director of Quoin Pharmaceuticals, Ltd., received 34,534 shares of common stock on August 27, 2026.
Summary
- Grant/award: acquired 34,534 ADSs at $5.15 ($177,850) on August 27, 2026; holds 56,243 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Dennis Langer — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Grant/award | ADSs | 34,534 | $5 | $177.9K | 56,243 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Grant/award (34,534 shares) |
Keywords
insider transaction, Form 4, QNRX, Quoin Pharmaceuticals, Ltd., neutral, Dennis Langer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.